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Infertility aﬀects 15% of all couples. Although male infertility factors with reduced semen quality are contributing to about half
of all involuntary childlessness, the value of standard semen parameters in prediction of fertility in vivo and choice of proper
method for assisted reproduction is limited. In the search for better markers of male fertility, during the last 10 years, assessment
of sperm DNA integrity has emerged as a strong new biomarker of semen quality that may have the potential to discriminate
between infertile and fertile men. Sperm DNA Fragmentation Index (DFI) as assessed by the ﬂow cytometric Sperm Chromatin
Structure Assay (SCSA) can be used for evaluation of sperm chromatin integrity. The biological background for abnormal DFI
is not completely known, but clinical data show that DFI above 30% is associated with very low chance for achieving pregnancy
in natural way or by insemination, but not in vitro. Already when the DFI is above 20%, the chance of natural pregnancy may
be reduced, despite other sperm parameters being normal. Thus this method may explain a signiﬁcant proportion of cases of
unexplained infertility and can be beneﬁcial in counselling involuntary childless couples need of in vitro fertilisation.
1.Introduction
In western countries up to one-forth of couples in reproduc-
tiveageareseekingmedicalhelpforinvoluntarychildlessness
[1]. Despite the signiﬁcant developments in the area of
fertility seen during the last decades about one-third of these
coupleswill beundiagnosedwithoutany explanationtotheir
problems.
Although, the traditional semen parameters concentra-
tion,motility,andmorphologyareagoldenstandard indiag-
nosing of male infertility it has become apparent that none
of these parameters recommended by the Word Health
Organization (WHO) [2]a r es u ﬃcient for the prediction of
male fertility capacity. As the WHO parameters only address
few aspects of sperm quality and function the discriminative
power in relation to fertility is quite low [3, 4].
As a result, there has for long been searched for better
markers of male fertility.
During the last decades the use of assisted reproductive
techniques (ARTs) has increased substantially [1, 5]. In par-
ticular intracytoplasmic sperm injection (ICSI) is used to an
increasing degree. While in the beginning of the era of ICSI
theindicationfortreatment was severemalefactor infertility,
now also couples with normal sperm quality request are
treated with ICSI. However, IVF and ICSI are symptomatic
treatments where only 25–30% of the treatments result in
a delivery [6]. One explanation to this limited success can
be the lack of markers to ﬁnd the underlying causes to
subfertility and also a lack of methods to identify the type
of ART treatment providing the most optimal chances of
pregnancy in a given couple.
During the last decade the search for better predictors of
male fertility has resulted in an increased focus on the sperm
DNA integrity [7, 8]. Now number of sperm chromatin in-
tegrity assays is available. Among the most frequently used
are the Comet assay (single cell gel electrophoresis) [9], the
TUNEL (terminal deoxynucleotidyl transferase-mediated
dUDP nick end labelling) assay [10], the sperm chromatin
dispersion (SCD) [11, 12], and the sperm chromatin struc-
ture assay (SCSA) [13, 14]. The clinical value of these diﬀer-
ent tests varies; however, SCSA, ﬁrst described by Evenson
et al. [13] is shown to be an independent marker of fertility
in vivo and may also help in selection of the most eﬀective
ART treatment in each individual couple [15]. This paper2 Obstetrics and Gynecology International
will discuss how sperm DNA integrity assessment by help
of SCSA can be used as a tool in diagnosis and treatment of
infertility.
2.AetiologyandDiagnosis ofInfertility
Involuntary childlessness, infertility can be a result offemale,
male as well as combined factors. It is a complex condition
where often a mix of factors plays a role. In 20% of cases,
the predominant cause is solely male related and, in another
30%, anomalies in both partners contribute to the childless-
ness [2]. Traditionally genital infections, endocrine distur-
bances, and immunological factors have been regarded as
the most common causes of male subfertility. However, now
more often genetic/molecular causes are identiﬁed as con-
tributing factors [16], as,for instance, chromatin defects
assessed as breaks in sperm DNA [7, 14, 17–19]. However,
it is a fact that in 60–75% of the male-caused cases the
aetiology of reduced semen qualityremains unexplained and
is therefore diagnosed as idiopathic infertility [2].
The golden standard in the diagnosis of male infertility
orsubfertility is an analysis ofsperm concentration,motility,
and morphology where WHO has set threshold levels for
normality in regard to fertility [2]. However, this WHO
sperm analysis is mainly performed by light microscopy of
100–200 spermatozoa and thus the analysis is biased because
of a high level of subjectivity resulting in a high grade
of intra- and interlaboratory variation [20, 21]. As a con-
sequence a low predictive value of the WHO analysis is
reported. Another drawback with the WHO parameters is
that they only address few aspects ofsperm qualityand func-
tion. During the last decades, several other sperm function
tests have been suggested to be used, including vital staining,
hemizona assay, biochemical analysis of semen, antisperm
antibody test, hypoosmotic swelling test, sperm penetration
assay, reactive oxygen species (ROS) tests, and computer-
assisted sperm analysis (CASA) [18]. However, as none of
them have provided stable threshold values few are actually
used in clinical routine [22].
Now an increasing amount of data demonstrate an asso-
ciation between sperm DNA damage and fertility [7, 14, 17,
19, 23–26]. It has been proposed that sperm DNA integrity
could be a fertility predictor to be used as a supplement to
the traditional sperm parameters [14, 15, 27].
3.Causesto SpermDNA Damage
Spermatogenesis is a complex process [28]w h e r ed a m a g eo f
sperm chromatin structure can occur at any step (reviewed
in [7]). DNA damage in sperm can be due to unrepaired
DNA breaks during the spermatogenetic chromatin remod-
eling and packaging or abortive apoptosis during sper-
matogenesis. Among other suggested causes are the eﬀect
of endogenous endonucleases and caspases, exposure to a
variety of genotoxic agents because of therapeutic reasons
or because of occupational or environmental exposures, and
ﬁnally, the action of oxidative sperm DNA damage [19].
Most likely often these factors are interrelating. Problems in
the crossing-over process during spermatogenesis or deﬁ-
ciencies in the protamination process will likely make sperm
more vulnerable to oxidative stress at a later occasion.
3.1. Remodeling and Packaging Problems. Meiotic crossing-
over during spermatogenesis is associated with the pro-
grammed introduction of DNA double-strand breaks, ex-
pected to be ligated until the end of meiosis I [29]. Stage-
speciﬁc introduction of transient DNA strand breaks during
spermiogenesis has been described [30, 31]. DNA breaks are
needed for transient relief of torsional stress, favouring the
histone replacement with protamines during the ﬁnal matu-
ration form round to elongated spermatozoa [31, 32]. How-
ever, if and only if these physiological, normal temporary
breaks are not repaired, DNA fragmentation in ejaculated
spermatozoa or genetic mutations may occur [33].
3.2. AbortiveApoptosis. Another suggested aetiology of DNA
damage is that breaks can arise through abortive apoptosis.
Apoptosis of testicular germ cells occurs normally through-
out life, controlling overproliferation [34]; however, it has
been suggested an early apoptotic pathway, initiated in sper-
matogonia and spermatocytes, mediated by the Fas protein
[35]. Sertoli cells in the testis express Fas ligand, which by
b i n d i n gt oF a sl e a d st oc e l ld e a t ht h r o u g ha p o p t o s i s[ 35].
3.3. Oxidative Stress. Oxidative stress (OS) caused by an im-
balance between the antioxidant ability in seminal plasma
and the production of reactive oxygen species (ROS) leading
to the formation of oxidative products such as 8OHdG is
the mechanism that probably most often lies behind sperm
DNA defects. The sperm cell membrane is easily attacked by
ROS with further detrimental eﬀects on nuclear membranes
as well as on sperm DNA [33]. Moreover, sperm lack anti-
oxidants and DNA repair systems [36] and therefore pro-
tection of the oﬀspring from the negative eﬀects of male-
i n d u c e dD N As t r a n db r e a k si sa l w a y sd e p e n d a n to nt h e
repair capacity ofthe oocyte and the early embryo. The main
sources of ROS in semen are leukocytes and abnormal/dead
spermatozoa in the semen [19, 37, 38]; however, increased
scrotal temperature due to illness with fever [39–41], varic-
ocele [42], increased age [43–47], and smoking [48–54]a r e
also reported as sources.
4.SpermDNA IntegrityAssessment
Currently, four major tests of sperm DNA fragmentation
are most frequently used, including the Comet assay (single
cell gel electrophoresis) [9], the TUNEL (terminal deoxynu-
cleotidyl transferase-mediated dUDP nick end labelling)
assay [10], the sperm chromatin dispersion (SCD) test [11,
12], and the sperm chromatin structure assay (SCSA) [13,
14]. They all label single- or double-stranded DNA breaks;
however unfortunately, most of the available techniques for
detection of sperm DNA damage provide limited informa-
tion on the nature of the DNA lesions detected and none
of them enables us to depict the exact aetiology and patho-
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Comet assay is a ﬂuorescence microscopic test, and
TUNELassaycanbeappliedinbothbrightﬁeld/ﬂuorescence
microscopy and by ﬂow cytometry. In Comet assay sperm
cellsaremixedwithmeltedagaroseandthenplacedonaglass
slide. The cells are lysed and then subjected to horizontal
electrophoresis. DNA is visualized with the help of a DNA-
speciﬁc ﬂuorescent dye and DNA damage is quantiﬁed by
measuring the displacement between the genetic material
of the nucleus comet head and the resulting tail. In the
TUNEL assay, terminal deoxynucleotidyl transferase (TdT)
incorporates labelled (by and large ﬂuorescent) nucleotides
to3 -OHatsingle-anddouble-strandDNAbreakstocreatea
signal, which increases with the number of DNA breaks. The
ﬂuorescence intensity of each analyzed sperm is determined
as a “positive” or “negative” for sperm on a microscope
slide. In a ﬂow cytometer the fraction of positive sperm is
represented by the cells above a threshold channel value on a
relative ﬂuorescent intensity scale.
SCSA is a ﬂowcytometric test where sperm DNA breaks
areevaluatedindirectlythroughtheDNAdenaturability.The
assay measures the susceptibility of sperm DNA to acid-
induced DNA denaturation in situ, followed by staining
with the ﬂuorescence dye acridine orange [13, 14, 55]. By
using a ﬂow cytometer 5.000–10.000 sperm can be analyzed
within few seconds and thus provide a less subjective result
compared to the WHO analysis where only 1–300 cells are
analyzed. Through a speciﬁc SCSA-software (SCSA-Soft) a
scatter plot is created, showing the ratio of green and red
sperm. The percentage of red sperm is called DNA fragmen-
tation index (DFI) [14]. The sperm with the most intensive
green colour is called high DNA stainable (HDS) sperm.
It is still unclear precisely which mechanisms and types of
DNA damage are lying behind DFI and HDS; however, it is
believed that whilst DFI is related to the percentage of sperm
with DNA breaks or protamine defects HDS is thought to
represent immature spermatozoa [14].
So far, the SCSA is the only sperm DNA integrity assess-
ment method which has demonstrated clear and clinically
useful cut-oﬀ levels for calculating male fertility potential
[13, 15, 27, 55]. The SCSA is a standardized test performed
according to a strict protocol [14]. Apart from being subject
to a very limited intralaboratory variation [56], however,
the SCSA analysis has shown to be very robust to variation
between laboratories. In an external quality control based
on >180 samples, a high (r = 0.8) correlation was found
between the values obtained by our laboratory and those
from a control laboratory. Furthermore, the absolute DFI
values obtained at two diﬀerent laboratories, using diﬀerent
equipment, did not on average diﬀer by >1% [57].
TheadvantageofSCSAistheobjectivityofthetestaswell
as the high reproducibility when running after the standard-
ised protocol. Moreover, the clear cut-oﬀ levels in relation
to fertility are maybe the most obvious beneﬁt compared
to other sperm DNA integrity tests. A disadvantage is that
an expensive ﬂow cytometer is required to run the analysis.
Moreover, the test irreversibly damages spermatozoa; after
analysis they cannot be used for fertilisation purposes.
Studies have demonstrated that these four sperm DNA
integrity tests, the SCSA, TUNEL, Comet, and SCD assays,
generally correlate moderately with each other (a coeﬃcient
of correlation between 0.4 and 0.7), which indicates that the
tests likely are expressing diﬀerent aspects of sperm DNA
damage.
5.SCSAandtheChanceofPregnancy
Two population-based studies, including 165 and 215 cou-
ples respectively, [13, 55], have demonstrated that DFI as
measuredwithSCSAisanexcellentpredictorofsubfecundity
in the normal population. In the interval of DFI 0–20%,
the chance of spontaneous pregnancy was constant. When
DFI was above 20% the chance of obtaining a spontaneous
pregnancy was decreased and close to zero when the DFI
level passed 30–40%. Even though DFI was below 20%,
only 13% of all cycles resulted in a pregnancy. Therefore,
in a normal population, not selected because of infertility
problems, SCSA is a valuable tool to identify men who are at
risk of not giving rise to a pregnancy. The same information
is not possible to get from the traditional WHO sperm
parameters. Evenamong menwith lowsperm concentration,
poormotilityormorphologytherewill bemenwith acertain
potential of fertility [3].
In a case-control study of 137 infertile and 127 fertile
men the risk of being infertile was found to be increased
when DFI as measured by SCSA was above 20% in men with
normal standard semen parameters, an odds ratio (OR) of
5.1, (CI: 1.2–23), compared to fertile controls [27]. If one of
the WHO parameters was abnormal, the OR for infertility
was increased already at DFI above 10% (OR 16, CI: 4.2–
60). A DFI above 20% was found in 40% of the men with
otherwise normal standard parameters. DFI was also shown
to be an independent predictor of spontaneous pregnancy.
Erenpreiss and coworkers found that 20% of the men with
otherwise normal WHO sperm parameters had an SCSA-
DFI above 20% [58].
The association between sperm DNA damage and the
traditional semen parameters is shown to be only weak to
moderate [57, 59]. It is also shown that 25–40% of infer-
tile men may have normal standard sperm characteristics
according to WHO criteria, buta DFI above 20–30%[15, 27,
58].
ART includes all technologies that involve the handling
of sperm outside the body, as in intrauterine insemination
(IUI), or handling of oocytes, sperm, and embryos as in in
vitro fertilization (IVF) and ICSI [60]. In IVF, the sperma-
tozoas ability to penetrate the zona pellucida of the oocyte
is utilized. In ICSI, however, one single spermatozoon is
selected and injected directly into the cytoplasm of the
oocyte.Despite these obviousdiﬀerencesmost studiesreport
results from the three types of treatments together. In
studies reporting the three treatment types separately, the
number of patients included and thus the statistical power
have been relatively low. The ﬁrst SCSA study to indicate
an association between sperm DNA damage and reduced
pregnancy chances was published by Saleh et al. [61]w h o
performed a small study where 12 of 19 couples had a DFI
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was obtained. Also, Boe-Hansen and coworkers in a study
on 48 IUI couples found only two couples with a DFI value
above 30%, and neither here pregnancy was obtained [62].
Recently, in a study of 387 IUI cycles, we have shown that
even in IUI SCSA-DFI can be used as an independent
predictor of fertility [15]. Whilst the proportion of children
born per cycle was 19.0% when the DFI value was below
30%, those with a DFI value above 30% only had a take-
home-baby rate of 1.5%. In this group the OR for delivery
in relation to DFI <30% was 0.07 (95% conﬁdence interval
(CI): 0.01–0.48). In the same study, 388 IVF and 223 ICSI
cycles were included but it was not possible to ﬁnd any
threshold value for DFI that could predict the result of the
treatments. However, surprisingly when DFI exceeded 30%,
the result of ICSI was signiﬁcantly better than IVF (OR
for delivery was 2.17 (CI 1.04–4.51)). These data are in
agreement with otherprevioussmaller reports using TUNEL
or COMETassays, showing that sperm DNAdamage is more
predictive in IVF and much less so in ICSI [63, 64].
Although fertilization and embryo development may be
independent of sperm DNA integrity, it has been suggested
that the postfertilization developmentofthe pre-embryo can
be impaired by such incomplete or aberrant sperm DNA
repair by the oocyte leading to early miscarriages (reviewed
in [65]) or in the worst cases diseases in the oﬀspring [8, 66,
67]. In our study of about 1000 couples no relationship was
seen between sperm DNA fragmentation and unexplained
pregnancy loss [15].
The otherSCSAparameter, HDS,was neitherinoursnor
in other studies found to be of predictive value of pregnancy.
6.ClinicalRecommendations
SCSArepresentsavaluabletoolindiagnosisandtreatmentof
infertility. The usefulness of the method is ﬁrst of all relating
to in vivo fertility (spontaneous pregnancy and IUI) and in
particular in the many couples diagnosed with unexplained
infertility. In 20% of men presenting with otherwise normal
semen parameters, the SCSA-DFI is above 30% and in these
c o u p l e st h ec h a n c eo fp r e g n a n c yi sc l o s et oz e r o[ 15]t h a ti s
why they should be directly referred to IVF/ICSI. Through
such a strategy change one-ﬁfth of all couples normally
referred to IUI can avoid the huge burden an unsuccessful
ART treatment represents.
In as many as 40% of all unexplained infertile couples
the explanation may be related to a high DFI. In a couple
having a DFI between 20 and 30% time to pregnancy will be
longer than in a couple with a DFI level below 20%. This
is important information that should be utilized in coun-
selling the couple. Combining SCSA-DFI with assessment
of traditional WHO sperm parameters is shown to give a
higher precision in the prediction of fertility. If one of the
WHO sperm parameters is that abnormal fertility becomes
reduced already when DFI exceeds the level of 10%, whereas
the DFI level is above 30%, couple should be revised directly
to IVF/ICSI. However, the status is that still very few clinics
have implemented sperm chromatin integrity testing and
therefore most couples seeking help for infertility problems
are not aware of their actual potential sperm DNA defects.
One reason is the necessity of expensive equipment as, for
instance, a ﬂow cytometer as well as time, cost, and expertise
to perform the analysis. On the other hand, sperm samples
can be shipped to and analyzed on a centralized SCSA labo-
ratory.
Sperm DNA breaks are mainly thought to be a result of
oxidative stress. Some reports demonstrating a positive eﬀect
of antioxidant therapy in men with a high DFI have been
published; however, the study populations have been small
anddataconﬂicting[45,68–73].InthefutureSCSAmayalso
have the potential to give indications for a causal treatment
of disturbances of male fertility.
Development of new improved tests depicting the cause
of sperm DNA damage should be the next step in using
sperm DNA integrity testing as a tool in diagnosis and treat-
ment of infertility.
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